A conversion chart for switching from Ozempic (semaglutide) to Mounjaro (tirzepatide) isn’t standardized, as these medications have different active ingredients, dosages, and mechanisms of action. It is crucial to follow medical advice when switching between them.
Overview of Medications
- Ozempic (Semaglutide): Approved for type 2 diabetes management, available in doses of 0.25 mg, 0.5 mg, 1 mg, and 2 mg.
- Mounjaro (Tirzepatide): A newer medication that targets both GLP-1 and GIP receptors, available in doses of 2.5 mg, 5 mg, 10 mg, and 15 mg.
Here’s a detailed conversion chart comparing Ozempic (Semaglutide) and Mounjaro (Tirzepatide) based on dosing and key characteristics:
| Parameter | Ozempic (Semaglutide) | Mounjaro (Tirzepatide) |
|---|---|---|
| Indication | Type 2 Diabetes, Weight Loss (off-label) | Type 2 Diabetes, Weight Loss (pending FDA approval) |
| Mechanism of Action | GLP-1 Receptor Agonist | Dual GIP/GLP-1 Receptor Agonist |
| Starting Dose | 0.25 mg once weekly (not therapeutic) | 2.5 mg once weekly (not therapeutic) |
| First Therapeutic Dose | 0.5 mg once weekly | 5 mg once weekly |
| Maximum Dose | 2 mg once weekly | 15 mg once weekly |
| Typical Dose Escalation | 0.25 mg to 0.5 mg after 4 weeks, then increase by 0.5 mg if needed | 2.5 mg to 5 mg after 4 weeks, then increase by 2.5 mg increments |
| Dosage Form | Pre-filled pen | Pre-filled pen |
| Onset of Action | 1-2 weeks | 1-2 weeks |
| Peak Effect | 4-5 weeks | 4-5 weeks |
| Administration Frequency | Once weekly | Once weekly |
| Common Side Effects | Nausea, vomiting, diarrhea, constipation, headache | Nausea, vomiting, diarrhea, reduced appetite |
| Efficacy for Weight Loss | Significant weight loss (up to 15% of body weight in some studies) | Significant weight loss (up to 20% or more in studies) |
| Contraindications | Personal/family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) | Same as Ozempic |
| Cost (without insurance) | Approx. $900-$1,200/month | Approx. $1,000-$1,200/month |
Dosage Conversion (General Comparison)
| Ozempic Weekly Dose | Comparable Mounjaro Weekly Dose |
|---|---|
| 0.25 mg | 2.5 mg |
| 0.5 mg | 5 mg |
| 1 mg | 10 mg |
| 2 mg | 15 mg |
Considerations Before Switching
- Consult Healthcare Provider: It is crucial to discuss any medication changes with a healthcare professional who can tailor recommendations based on individual health needs.
- Side Effects: Both medications may cause side effects such as nausea, diarrhea, and abdominal pain, which typically decrease over time.
- Weight Management: Mounjaro has shown superior weight loss results compared to Ozempic in clinical trials, making it a favorable option for patients focused on weight management alongside diabetes control.
Switching from Ozempic to Mounjaro can enhance treatment efficacy for many patients with type 2 diabetes, but it must be approached with careful planning and medical guidance.
Sources used: